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CC BY-NC-ND license (http://creativeAbstract Objective: The purpose of this study was to observe the anti-cancer activity of Ton-
glian decoction (TD) on esophageal cancer (EC) cells in vitro, and to elucidate the related mo-
lecular mechanisms in the cell cycle and PI3K/Akt signaling pathway.
Methods: EC9706 cells were cultured in RPMI 1640 medium supplemented with 10% calf serum
at 37C in a 5% CO2 incubator. The cells were treated with rat serum containing TD or the
serum of rats administered Xiaoaiping as a positive control drug. Cell proliferation was as-
sessed by methylthiazolyldiphenyl-tetrazolium bromide assays. Cell morphology was observed
under a microscope. The cell cycle was examined by flow cytometry. Protein expression in the
PI3K/Akt signaling pathway was measured by western blotting.
Results: TD mainly inhibited cell proliferation. Concentrations of 50% cell inhibition by rat
serum containing TD or Xiaoaiping were 73.6 and 153.8 mL/mL, respectively. TD also influ-
enced cell morphology characterized by small shrunken cells. Cell colonies became small
and the cell proliferation rate was slower. In cell cycle analysis, the percentage of cells in
S phase was decreased significantly by TD and Xiaoaiping compared with the blank control
group (P < .05). Western blotting showed that serum containing TD strongly down-
regulated EGFR, PI3K, Akt, p-Akt, and mTOR expression compared with the blank control
group (P < .05).5133918389; fax: þ86 315 3726292.
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progression in S phase. The possible mechanism was inhibition of multiple targets in the
PI3K/Akt signaling pathway by TD.
ª 2015 Beijing University of Chinese Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Esophageal cancer (EC) was the fifth most commonly
diagnosed cancer and the fourth leading cause of cancer-
related death in China in 2009.1 The average incidence of
EC is 21.62/100,000 and mortality is 16.25/100,000 in
2011.2 There is regional variation of EC incidence with the
highest rates at the borders of Henan, Shanxi and Hebei
provinces.3 As an important complementary and alternative
medicine, traditional Chinese medicine (TCM) has shown
significant effects in treating this disease in recent years
with few side effects.
A study has identified that the pathogenesis of blood
stasis and stagnation of Qi have a close relationship with
over-expression of proteins in the PI3K/Akt signaling
pathway of EC9706 cells.4 The Chinese medicinal formula
Tonglian decoction (TD) has been approved as a National
Invention Patent of China.5 TD is applied to treat EC by
activating the blood and promoting Qi.
This study focused on the anti-cancer activity of TD in
EC. EC9706 cells were treated with rat serum containing TD
and then cell proliferation, morphology and the cell cycle
were examined. Protein expression of the PI3K/Akt
signaling pathway was determined to elucidate the mo-
lecular mechanism of the anti-cancer effects.
Xiaoaiping tablet, which is widely used to treat EC in
clinic, is a qualified drug approved by National Food and
Drug Administration of China. The ingredients in Xiaoaiping
are extracted from Caulis marsdeniae tenacissimae, a
Chinese herbal plant growing in south-west of China. The
plant contains anti-cancer substances which could elimi-
nate cancer hormones and disrupt cancer cell proliferation
or metastasis.6 So Xiaoaiping was applied as a positive drug
in this study to evaluate effect of TD on EC cells
objectively.
Materials and methods
Experimental animals
Twenty-one male SpragueeDawley (SD) rats (220  20 g)
were purchased from the National Institute for Food and
Drug Control (Beijing, China). All animals were housed
under specific pathogen-free conditions and had free ac-
cess to water and standard rat feed. The experiment was
approved by ethics committee of North China University of
Science and Technology and the number of animal experi-
mental ethical inspection form is 2014-023.Cells and culture conditions
EC9706 human EC cells were a gift from the Tumor Insti-
tute, Beijing Union Medical College. EC9706 cells were
cultured in RPMI 1640 medium supplemented with 10% calf
serum (CS) at 37C in a 5% CO2 incubator.
Drugs and reagents
TD is comprised of six Chinese herbs: oldenlandia (Old-
enlandia diffusa (Willd.) Roxb.) safflower (Carthamus
tinctorius L.), peach kernel (Prunus persica (L.) Batsch),
bugbane rhizome (Cimicifuga foetida L.), betel nut (Areca
catechu L.), and bearded scutellaria (Scutellaria barbata
D.Don) (dosage proportion, 3:3:1:1:1:2). All herbs were
purchased from Tongrentang (Beijing, China). The phar-
maceutical preparation section of the Affiliated Hospital of
North China University of Science and Technology was
responsible for preparation and quality control of the for-
mula. Xiaoaiping tablets (lot No.: 110706) were purchased
from Sanhome (Nanjing, China). RPMI 1640 medium and CS
were purchased from Gibco (Grand Island, NY, USA). Trypsin
was purchased from Cusabio (Wuhan, China).
Methylthiazolyldiphenyl-tetrazolium bromide (MTT) and
dimethyl sulfoxide were purchased from Amresco (Solon,
OH, USA). RNaseA and propidium iodide (PI) were pur-
chased from SigmaeAldrich (St. Louis, MO, USA). The
following antibodies were purchased from Cell Signaling
Technology (Danvers, MA, USA): anti-EGFR monoclonal
antibody, anti-PI3K polyclonal antibody, anti-Akt mono-
clonal antibody, anti-p-Akt monoclonal antibody, and anti-
mTOR monoclonal antibody.
Scientific apparati
The following scientific instrumentation were used in this
study: laminar airflow workstation (model 1100; Thermo
Fisher Forma, Waltham, MA, USA); ultrasonic processor
Sonics and Materials (Vibra-Cell 750; Sonics and Materials,
Newton, CT, USA); CO2 incubator (model 3336; Thermo
Fisher Forma); The inverted microscope (model Diaphot
TMD; Nikon Instruments, Melville, NY, USA); The fluores-
cence microscope (model EF-D, Nikon); FACSCalibur flow
cytometry system (model FACSCalibur, BD Biosciences, San
Jose, CA, USA). The mini-slab electrophoresis system
(model AE-6531 mPAGE, ATTO, Tokyo, Japan); enzyme
immunoassay (EIA) microplate reader (model Elx800, Bio-
Tek, Winooski, VT, USA).
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Using a random number table, 21 male SD rats were divided
into blank control (BC), positive control drug (PC, Xiaoaip-
ing tablets), and TD groups (n Z 7 each). The clinical
dosages of TD (raw powder) and Xiaoaiping were 58 and 9 g/
d, respectively, which are 828 and 129 mg/kg per day ac-
cording to the 70 kg standard adult weight. The scaled rat
dosages were 75 mg/kg per day (TD) and 11.5 mg/kg per
day (Xiaoaiping). Rats received gastric lavage with the
drugs for 5 days continuously. The same volume of normal
saline was administered to rats in the BC group by lavage.
Rats were maintained under nesteia for 12 h before the last
lavage. After 12 h, pentobarbital sodium (1.5 mL/kg) was
applied for intraperitoneal anesthesia, and blood was
sampled through the aorta abdominalis. Serum was isolated
and inactivated for 30 min at 56C in a water bath. Serum
was sterilized by passing through a 0.22 mm millipore filter
and then stored at 80C.
MTT assay
EC9706 cells were seeded on 96-well plates at a concen-
tration of 1  104 cells/well in complete culture medium
and allowed to adhere for 24 h. The adherent cells were
incubated in the presence of various amounts of serum (0%,
2%, 4%, 6%, 8% and 10%) for 48 h and then subjected to MTT
assays. The optical density (OD) of the treated samples in
comparison with the BC group was measured with the EIA
photometer. The wavelength for measuring the absorbance
of the formazan product was 570 nm. The experiment was
repeated three times. A fitting curve of dose-effect
dependence was constructed and the median effective
dose (IC50) was calculated by SPSS 18.0 software (SPSS,
Chicago, IL, USA) according to the following formula7:
Inhibition rate of EC9706 cells by serum Z (1OD of me-
dicinal groups/OD of control group)  100%.Dose dependent manner of serum containing drugs inhibiting
EC9706 cells proliferation
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Fig. 1 Dose-dependent effect of rat serum containing drugs
on inhibition of EC9706 cell proliferation. EC9706 human EC
cells were seeded in 96-well plates and treated with various
concentrations of TD and Xiaoaiping for 48 h. Three samples
were tested for each treatment group. Data are expressed as
the mean  standard error of the mean and were analyzed by
the paired t-test. The experiment was repeated three times.
aP < .05 versus the PC group.Observation of cell morphology by microscopy
EC9706 cells were seeded in 100 mm dishes at a concen-
tration of 1  106 cells/dish in 10 mL culture medium/dish
and incubated at 37C in a 5% CO2 incubator for 24 h. Serum
containing drugs (IC50 concentration) was then added to
medicinal groups, while the BC group was maintained in
RPMI 1640 medium containing 10% normal rat serum for
48 h. Cell growth and morphological changes were observed
under an inverted microscope.8
Cell cycle analysis by flow cytometry
Cells were seeded in 100 mm dishes at a concentration of
1  106 cells/dish in 10 mL culture medium/dish and
incubated at 37C in a 5% CO2 incubator for 24 h. Serum
containing drugs (IC50 concentration) was added to the
culture medium, and the cells were cultured for another
24 h. The cells were collected and bathed in 70% ethanol/
PBS. The cells were washed and then treated with 10 mL,
10 mg/mL RNaseA, 1% Triton-100, and then 1 mg/mL PI inturn for 5 min each. The cells were filtered through a
400 mm mesh prior to flow cytometry. Cell Quest Pro and
Modifit LT software were used to analyze the cell cycle. The
percentage was calculated in each cell cycle phase.9Determination of protein expression in the PI3K/
Akt signaling pathway by western blotting
Cells were seeded in 100 mm dishes at a concentration of
1  106 cells/dish in 10 mL culture medium/dish and
cultured at 37C in a 5% CO2 incubator. Serum with or
without drugs (IC50 concentration) was added to the culture
medium, and the cells were cultured for 24 h. The cells
were collected, lysed by ultrasound, and then centrifuged
at 1676 g for 20 min. The supernatant was collected and the
protein concentration was determined by the Bradford
method.10 Samples were stored at 20C until analysis.
Proteins samples were subjected to 8% sodium dodecyl
sulfate polyacrylamide gel electrophoresis. Electrotransfer
was conducted for 8 h. Ponceau was used for staining.
Membranes were blocked and antigeneantibody reactions
were conducted for 4 h. Then the membranes were
developed by enhanced chemiluminescence and exposed to
X-ray film.11 Image J software (National Institutes of
Health, USA) was used to analyze the grey values.Statistical analysis
Continuous variables are expressed as the mean  standard
deviation. All samples were tested to determine whether
they followed homogeneity of variance by one-way analysis
of variance. Assuming the data had a normal distribution,
least significant difference (LSD) was applied to compare
differences between two groups. If data had an abnormal
distribution, Dunnett’s T3 was used. A value of P < .05 was
regarded as statistically significant. SPSS 18.0 software was
used for statistical analysis.
Fig. 2 Fitting curve of the dose-dependence of EC9706 cell inhibition by rat serum containing drugs. Fitting curves were con-
structed with SPSS 18.0 software, F-test. Dots indicate the actual values. The curves were fitted according to the actual values. A
different formula was used in SPSS, to estimate the approximate IC50 values.
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Drugs sensitivity of EC9706 cells
Administration of serum containing drugs inhibited cell
proliferation in a dose-dependent manner. The effect of TD
was much stronger than that of Xiaoaiping. There was aFig. 3 Growth and morphology of cells treated with rat serum co
400 magnification. Drug dosages were as follows: normal serum
centration of 73.6 mL/mL in the TD group, and IC50 serum concentsignificant difference between the two groups in terms of
the inhibition ratio (P < .05). Within the test concentra-
tions, serum containing TD had a peak value at 8%.
Conversely, the IC50 of the PC group was outside of the test
concentrations. The F-test fitting curve showed that the
IC50 concentration of serum containing TD was 73.6 mL/mL,
and the IC50 concentration of the PC group was 153.8 mL/mL
(Figs. 1 and 2).ntaining drugs. Samples were observed in five fields of vision at
concentration of 100 mL/mL in the BC group, IC50 serum con-
ration of 153.8 mL/mL in the PC group.
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Fig. 5 Comparison of the ratio of EC9706 cells treated with
rat serum containing drugs in cell cycle phases. Three samples
were analyzed for each group. Drug dosages were as follows:
normal serum concentration of 100 mL/mL in the BC group,
IC50 serum concentration of 73.6 mL/mL in the TD group, and
IC50 serum concentration of 153.8 mL/mL in the PC group. Data
are expressed as mean  standard error of mean and analyzed
by the LSD test. aP < .05 versus the BC group.
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with rat serum containing drugs
Cell density in the BC group was much higher than that in
the TD group. Cells proliferated rapidly with close con-
nections in an adherent state and maintained their spindle-
like shape. Cells in the TD group appeared to be small and
shrunken. Cell colonies were small and the proliferation
rate was low. Cells reduced sharply and vacuole material
emerged intracellularly. In the PC group, cell morphology
was similar to that in the TD group, but the cell number was
much higher than that in the TD group, which was accom-
panied by close connections between cells (Fig. 3).
Cell cycle analysis
The percentages of cells in S phase of medicinal groups
were 12.82% (TD group) and 15.26% (PC group), which was
much lower than that in the BC group (Fig. 4). As shown in
Fig. 5, there was a significant difference between medicinal
groups and the BC group (P < .05). However, the percent-
ages of cells showed no difference between medicinal
groups (Fig. 5).
Expression of proteins in the PI3K/Akt signaling
pathway
Western blotting was used to measure EGFR, PI3K, Akt, p-
Akt, and mTOR levels. The TD group showed significant
inhibition of the protein expression of the PI3K/Akt
signaling pathway. Compared with the BC group, protein
expression in medicinal groups was significantly different
(Fig. 6). In semi-quantitative analysis with Image JFig. 4 Cell cycle distribution of EC9706 cells treated with rat seru
each group. Three samples were observed for each group. Drug dosa
in the BC group, IC50 serum concentration of 73.6 mL/mL in the TD
group.software, grey values of the five proteins in the TD group
were much lower than those in the BC group (P < .05)
(Table 1).Discussion
TCM theory states that blood stagnation is important in the
pathogenesis of cancers.12 When cancers grow, blood
stagnation worsens and blocks Qi circulation. In ancient
China, many practitioners attached importance to blood
stasis and Qi stagnation in terms of cancer. TD, which has
been approved as a National Invention Patent of China,m containing drugs. A total of 50,000 events were recorded for
ges were as follows: normal serum concentration of 100 mL/mL
group, and IC50 serum concentration of 153.8 mL/mL in the PC
Fig. 6 Protein expression of the PI3K/Akt signaling pathway
in cells treated with rat serum containing drugs. Drug dosages
were as follows: normal serum concentration of 100 mL/mL in
the BC group, IC50 serum concentration of 73.6 mL/mL in the
TD group, and IC50 serum concentration of 153.8 mL/mL in the
PC group.
Tonglian decoction against esophageal cancer cell proliferation 125originated from TCM theory in terms of the pathogenesis of
EC influenced by blood and Qi stagnation.
There are six kinds of herbs in the TD formula. Hetero-
bathmia diffusa and S. barbata are used to clear away heat
and detoxification, removing stagnation and toxicity in the
body. Areca nut tends to decease and move stagnation of Qi
together with Cimicifuga that elevates nutrients and de-
creases turbidity in the body. Both facilitate Qi in the
spleen and stomach. C. tinctorius and Semen Persicae act
together. Each strengthens the other to activate blood and
promote Qi. The formula works in two aspects: removal of
pathogenic factors and cultivation of healthy Qi.
This study focused on the influence TD on EC9706 cell
behavior including cell proliferation, morphology, the cell
cycle, and PI3K/Akt signaling pathway to determine
whether TD might affect EC onset and development.
Xiaoaiping, which has been approved as a National qualifiedTable 1 Relative grey values of proteins ðX sÞ.
EGFR/b-actin PI3K/b-actin A
Group BC 1.534  0.336 2.340  0.409 2
Group TD 0.785  0.216a 1.102  0.350a 1
Group PC 0.859  0.302a 1.327  0.571a 0
Grey values were estimated by Image J software. Three samples were
error of mean and analyzed by the LSD test.
a P < .05 versus the BC.pharmaceutic, served as positive control drug. It is an
extract from Marsdenia tenacissima, an herb that grows in
South West China.
Different concentrations of rat serum containing drugs
led to different degrees of EC9706 cell inhibition. As shown
in Fig. 1, with increasing concentrations of serum, the in-
hibition rates increased correspondingly in a direct manner.
Serum containing TD had a much stronger effect than serum
containing Xiaoaiping with a IC50 value of only 73.6 mL/mL.
Morphological observations supported the results of MTT
assays, revealing fewer cells in the TD group, which were
small and shrunken. In contrast, the cell density in the BC
group was much higher at 70% confluence. Cells maintained
their spindle-like appearance with close connections.
These observations indicated that rat serum containing TD
provided an inhibitive environment for cell growth.
The cell cycle refers to the process of mitosis.13 A typical
cell cycle has four phases, G1, S, G2, and M, which are
controlled by signal transduction and a feedback loop.
Abnormal modulation of the cell cycle is a major mecha-
nism of carcinogenesis.14 A malignant tumor cell cycle is
uncontrolled and will hinder cell differentiation while
driving excessive proliferation.15 The proportion of cells in
S, G2 and M phases reflects active proliferation, which, to
some extent, indicates the condition of cell proliferation.16
Cells in G1 phase indicate suppression of cell proliferation.
After application of TD, the distribution of cells in G1, S, G2
and M phases changed compared with the control group. As
shown in Figs. 4 and 5, there were fewer cells in S phase
after application of TD and Xiaoaiping compared with the
BC group, indicating that TD inhibited EC9706 cell prolif-
eration by blocking carcinoma cells from entering S, G2 and
M phases.
PI3K/Akt signaling pathway can regulate cellular pro-
cesses including cell cycle progression, cell survival and
migration, and protein synthesis. Owing to kinds of extra-
cellular growth factors up-regulating, PI3K/Akt signaling
pathway will be activated, which is one of reasons leading
to occurrence and development of human cancer.17,18
Activation of the PI3K/Akt pathway has been reported to
be conducive to EC cells survival in vitro as well as
in vivo.19,20 What’s more, it has been proved that cell
cycle-related proteins (such as cyclin D1 and p27) were
regulated by the PI3K/Akt pathway in human EC cells.21
Protein expression of PI3K/Akt pathway has close relation
to cell cycle, which is a possible mechanism to elucidate
change of cell cycle in EC cancer.
Western blotting showed that rat serum containing TD
down-regulated protein expression in PI3K/Akt signaling
pathway of EC9706 cells, including EGFR, PI3K, Akt, p-Akt,kt/b-actin p-Akt/b-actin mTOR/b-actin
.252  0.587 0.939  0.245 1.233  0.465
.166  0.471a 0.433  0.134a 0.944  0.238
.597  0.189a 1.007  0.346 0.436  0.178a
analyzed for each group. Data are expressed as mean  standard
126 Y. Jia et al.and mTOR. This indicated that the specific mechanism of
the anti-EC effects of TD involved multiple targets. Semi-
quantitative analysis indicated that TD and Xiaoaiping had
significant inhibitory effects on protein expression
compared with the BC group, (P < .05), which inhibited EC
cell growth.
Conclusion
Based on the results, TD inhibits EC cell proliferation
in vitro. The mechanism is associated with regulation of the
cell cycle through the PI3K/Akt signaling pathway. Howev-
er, these are only in vitro results and TD should be tested
in vivo and in a clinical trial.
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